Back to search

Article

A Prospective Study Investigating the Efficacy and Toxicity of Definitive ChemoRadadiation and ImmunOtherapy (CRIO) in Locally and/or Regionally Advanced Cutaneous Squamous Cell Carcinoma.

2020-10-09

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Patients with unresectable advanced cutaneous squamous cell carcinoma (cSCC) are generally treated with palliative intent. Immune checkpoint blockade has significant activity in the palliative setting in patients with recurrent or metastatic cSCC. This single arm phase 2 prospective study aims to investigate the combination of curative intent chemoradiation and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d2d3a044-5eb3-5640-a672-54e892d43213
DOI
10.21203/rs.3.rs-88311/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Prospective Study Investigating the Efficacy and Toxicity of Definitive ChemoRadadiation and ImmunOtherapy (CRIO) in Locally and/or Regionally Advanced Cutaneous Squamous Cell Carcinoma.DOI 10.21203/rs.3.rs-88311/v1
Lymphatic-Preserving Treatment Sequencing with Immune Checkpoint Inhibition Unleashes cDC1-Dependent Antitumor Immunity in HNSCCSemantic proximity
Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 NeoTrio trial.Semantic proximity
Combination of immunotherapy and anti-EGFR agents in immunotherapy refractory head neck cancer recurrent and metastatic head neck squamous cell carcinomaSemantic proximity
Concurrent Chemoradiation in Locally Advanced Lung Cancer with Cisplatin–Etoposide or Carboplatin–Paclitaxel: An Institutional AnalysisSemantic proximity
Neoadjuvant immune-modulating SBRT and anti-CD73 to increase response to anti-PD-L1 and chemotherapy in early ER+/HER2- breast cancer: primary endpoint and translational results from the randomized Neo-CheckRay trialSemantic proximity
Image guidance improves freedom from recurrence in superficial radiation therapy for non-melanoma skin cancerSemantic proximity
Radiation Induced Checkpoint Immunotherapy Response in Refractory Colorectal and Pancreatic AdenocarcinomaSemantic proximity
Predictive role of circulating tumor DNA and blood-based tumor mutational burden in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab: Exploratory analyses of a phase II study (EC-CRT-001)Semantic proximity
Comparison of Neoadjuvant Chemoimmunotherapy and Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Retrospective Study with 3-Year Survival AnalysisSemantic proximity
Combinatorial delivery of low-dose irradiation and immunotherapy to patients with immune-excluded tumors effectively enhances CD8<sup>+</sup>T cell functionalitySemantic proximity
BRAF Mutation Correlates with Worse Local-regional Control Following Radiation Therapy in Patients with Stage III MelanomaSemantic proximity
Evidence for Efficacy of Treatment With the Anti-PD-1 Mab Nivolumab in Radiation and Multichemorefractory Advanced Penile Squamous Cell Carcinoma.Semantic proximity
Select a neighboring publication to make it the new centre.